125 related articles for article (PubMed ID: 11986945)
21. Leukemic T cells are specifically enriched in a unique CD3(dim) CD7(low) subpopulation of CD4(+) T cells in acute-type adult T-cell leukemia.
Tian Y; Kobayashi S; Ohno N; Isobe M; Tsuda M; Zaike Y; Watanabe N; Tani K; Tojo A; Uchimaru K
Cancer Sci; 2011 Mar; 102(3):569-77. PubMed ID: 21205081
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of genetically defined tumor cells in CD7 as well as CD26 positive and negative circulating T-cell subsets in Sézary syndrome.
Steinhoff M; Schöpp S; Assaf C; Muche M; Beyer M; Sterry W; Lukowsky A
Leuk Res; 2009 Jan; 33(1):88-99. PubMed ID: 18672285
[TBL] [Abstract][Full Text] [Related]
23. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
24. Apoptotic responses to all-trans retinoic acid of targretin-resistant, malignant, CD4+ peripheral blood T cells from patients with Sezary syndrome.
Newton SB; Yoon JS; Benoit BM; Wysocka M; Rook AH
Arch Dermatol; 2007 May; 143(5):661-2. PubMed ID: 17515523
[No Abstract] [Full Text] [Related]
25. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
26. Loss of CD7, independent of galectin-3 expression, implies a worse prognosis in adult T-cell leukaemia/lymphoma.
Liu TY; Chen CY; Tien HF; Lin CW
Histopathology; 2009 Jan; 54(2):214-20. PubMed ID: 19207946
[TBL] [Abstract][Full Text] [Related]
27. A Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients.
Autran B; Legac E; Blanc C; Debré P
J Immunol; 1995 Feb; 154(3):1408-17. PubMed ID: 7529803
[TBL] [Abstract][Full Text] [Related]
28. Sezary cell-like leukemia: a distinct type of mature T cell malignancy.
Matutes E; Keeling DM; Newland AC; Scott CS; Mitchell D; Traub N; Wardle DG; Catovsky D
Leukemia; 1990 Apr; 4(4):262-6. PubMed ID: 2366582
[TBL] [Abstract][Full Text] [Related]
29. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.
Fukumori T; Takenaka Y; Yoshii T; Kim HR; Hogan V; Inohara H; Kagawa S; Raz A
Cancer Res; 2003 Dec; 63(23):8302-11. PubMed ID: 14678989
[TBL] [Abstract][Full Text] [Related]
30. Double-positive CD4(+)CD8(+) Sézary syndrome: an unusual phenotype with an aggressive clinical course.
Wu R; Zippin JH; Magro C
Cutis; 2014 Feb; 93(2):E18-25. PubMed ID: 24605355
[TBL] [Abstract][Full Text] [Related]
31. CD7 expression and galectin-1-induced apoptosis of immature thymocytes are directly regulated by NF-kappaB upon T-cell activation.
Koh HS; Lee C; Lee KS; Ham CS; Seong RH; Kim SS; Jeon SH
Biochem Biophys Res Commun; 2008 May; 370(1):149-53. PubMed ID: 18355446
[TBL] [Abstract][Full Text] [Related]
32. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
[TBL] [Abstract][Full Text] [Related]
33. CD7- T cells represent a subset of normal human blood lymphocytes.
Reinhold U; Abken H; Kukel S; Moll M; Müller R; Oltermann I; Kreysel HW
J Immunol; 1993 Mar; 150(5):2081-9. PubMed ID: 7679701
[TBL] [Abstract][Full Text] [Related]
34. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
35. Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7.
Bremer E; Samplonius DF; Peipp M; van Genne L; Kroesen BJ; Fey GH; Gramatzki M; de Leij LF; Helfrich W
Cancer Res; 2005 Apr; 65(8):3380-8. PubMed ID: 15833872
[TBL] [Abstract][Full Text] [Related]
36. High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of response.
Raphael BA; Shin DB; Suchin KR; Morrissey KA; Vittorio CC; Kim EJ; Gardner JM; Evans KG; Introcaso CE; Samimi SS; Gelfand JM; Rook AH
Arch Dermatol; 2011 Dec; 147(12):1410-5. PubMed ID: 21844430
[TBL] [Abstract][Full Text] [Related]
37. A case of Sézary syndrome associated with cutaneous transformation.
Sakai H; Matsuo S; Matsumoto M; Iizuka H
J Dermatol; 1996 Oct; 23(10):697-702. PubMed ID: 8973035
[TBL] [Abstract][Full Text] [Related]
38. HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformation.
Akl H; Badran BM; Zein NE; Bex F; Sotiriou C; Willard-Gallo KE; Burny A; Martiat P
Leukemia; 2007 Apr; 21(4):788-96. PubMed ID: 17287851
[TBL] [Abstract][Full Text] [Related]
39. CD7(-) T cells are late memory cells generated from CD7(+) T cells.
Rappl G; Schrama D; Hombach A; Meuer EK; Schmidt A; Becker JC; Abken H
Rejuvenation Res; 2008 Jun; 11(3):543-56. PubMed ID: 18593274
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome.
van der Fits L; van Kester MS; Qin Y; Out-Luiting JJ; Smit F; Zoutman WH; Willemze R; Tensen CP; Vermeer MH
J Invest Dermatol; 2011 Mar; 131(3):762-8. PubMed ID: 21085192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
